Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 654 pseudogene (LOC100419761, ENSG00000255413) is classified as a *pseudogene*. Pseudogenes are DNA sequences that resemble protein-coding genes but have lost the ability to encode functional proteins due to mutations such as insertions, deletions, or premature stop codons. Consequently, they do not produce functional protein products and are generally not associated with classical molecular functions, biological roles in disease, druggability, or safety concerns. Pseudogenes can occasionally play indirect roles in gene regulation, for example by acting as competitive endogenous RNAs, but there is no evidence that this specific pseudogene is clinically or therapeutically relevant. The functional zinc finger protein 654 (ZNF654, ENSG00000175105) is a *DNA-binding transcription factor* that may be involved in gene regulation and has been associated with rare diseases, but the pseudogene (your query) does not share these direct functions[5][1][7][8]. **Key notes:** - This entry is not a protein, enzyme, receptor, transporter, or other druggable target—it is a nonfunctional genome element. - Treating it as a therapeutic target would be incorrect. - For information on the actual functional gene/protein, see *zinc finger protein 654 (ZNF654, ENSG00000175105)*[5]. If you require human druggable target information, you should focus on confirmed protein-coding genes, not pseudogenes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 654 pseudogene.